Kofta 250mg Injection
Marketer
Merlyn Biotech
Salt Composition
Ceftazidime (250mg)
Overview Kofta 250mg Injection
Ceftazidime 250mg Injection, an antibacterial medication, combats various bacterial infections. Its efficacy extends to infections affecting the brain, lungs, ears, urinary tract, skin, soft tissues, bones, joints, blood, and heart. Prophylactically, it's administered before surgery to prevent infection. This injection halts bacterial growth, alleviating symptoms and resolving the infection. Administered intravenously or intramuscularly by a healthcare provider, dosage is determined by your physician. Consistent, evenly-spaced doses, as directed, are crucial; complete the entire course, even with symptom improvement, to avoid relapse. Common side effects include rash and diarrhea; localized redness or injection-site pain may also occur temporarily. Inform your doctor if side effects persist or worsen. Prior to use, disclose any antibiotic allergies, liver or kidney issues, and all other medications you're taking, as interactions may occur. Pregnant or breastfeeding individuals should seek medical advice before use.
Uses of Kofta 250mg Injection
Infections caused by bacteria
Major Benefits of Kofta 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kofta 250mg Injection:
- Rash
- Allergic reaction
- Injection site reaction
- Diarrhea
How to use Kofta 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kofta 250mg Injection works:
Cefotaxime 250mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, thereby preventing bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Kofta 250mg Injection use.
PregnancySAFE IF PRESCRIBED
Employing Kofta 250mg Injection during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no harmful consequences for the fetus; nonetheless, research involving human subjects is currently insufficient.
Breast feedingSAFE IF PRESCRIBED
The 250mg Kofta Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to the infant. However, extended Kofta 250mg Injection use should be avoided due to potential side effects including diarrhea and skin rashes.
DrivingUNSAFE
Administering Kofta 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Administering Kofta 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Kofta 250mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Kofta 250mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Kofta 250mg Injection may be necessary. Physician consultation is recommended.
What if you forget to take Kofta 250mg Injection :
Omit a Kofta 250mg Injection? Seek your physician's advice.
Facts to Know About Kofta 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-spectrum cephalosporins (generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Third-generation cephalosporins |
3,018 People bought this recently